Results 171 to 180 of about 11,382 (203)

BRD4: epigenetic origin and target of CTCL

Blood, 2018
In this issue of Blood , Kohnken et al demonstrate a novel oncogenic pathway featuring IL-15-miR-29b-BRD4 positive feedback loop and targeting bromodomain-containing protein 4 (BRD4) disables the oncogenic loop, identifying a potentially effective target for therapy for cutaneous T-cell lymphoma (CTCL) patients ...
Xiaohong Zhao, Jianguo Tao
openaire   +2 more sources

Mogamulizumab Tops Standard of Care for CTCL

Cancer Discovery, 2018
Abstract In the large international phase III MAVORIC trial, patients with previously treated cutaneous T-cell lymphoma who received the anti-CCR4 monoclonal antibody mogamulizumab experienced significantly longer progression-free survival and higher response rates, as well as better quality of life, than those who received vorinostat, a
openaire   +2 more sources

The difficult—and often delayed—diagnosis of CTCL

Science Translational Medicine, 2015
High-throughput sequencing of T cell receptors to define and quantify T cell populations emerges as a diagnostic tool with the remarkable ability to discriminate between CTCL and benign inflammatory conditions (Kirsch et al ., this issue).
Jason, Weed, Michael, Girardi
openaire   +2 more sources

CTCL-Therapie mit Mogamulizumab

Oncology Research and Treatment, 2022
openaire   +2 more sources

The unseen burden of CTCL caregiving.

Journal of Clinical Oncology
e19059 Background: Cutaneous T-cell lymphoma (CTCL) patients rely heavily on informal caregivers for complex psychosocial and medical support. While crucial for patient outcomes, these caregivers face unique psychological challenges balancing care responsibilities with their own emotional needs.
Tatenda Merken, Rebecca D. Pentz, Kenya I. Apongule, Charles E. Waldner, Margie Dixon, Brittany La-Sha Adams, Darina Paulino, Pamela Blair Allen, Zachary Wolner, Nishanth Arumugam, Joel Andrews, Angela Ballard Oden, Mary Jo Lechowicz   +12 more
openaire   +1 more source

Bexarotene monotherapy for epidermotropic CD8+ CTCL.

Dermatologic clinics, 2008
Udgivelsesdato: 2008 ...
Kamstrup, M., Gniadecki, R.
openaire   +1 more source

Masernimpfvirus-Behandlung in CTCL

Aktuelle Dermatologie, 2003
PA Oberholzer, L Heinzerling, T Maier, A Tassis, T Kündig, G Burg, R Dummer   +6 more
openaire   +1 more source

Incidence of CTCL in Vietnam veterans.

Dermatology nursing, 2002
The causative factors of cutaneous T-cell lymphoma (CTCL) are unclear. Exposure to herbicides has been linked to the development of other lymphomas. Three Vietnam Veterans with CTCL treated at a photopheresis unit in New Jersey report positive histories of exposure to Agent Orange, a herbicide used during the war.
openaire   +1 more source

HSCT prolongs remission of high-risk CTCLs

Nature Reviews Clinical Oncology, 2023
openaire   +2 more sources

CTCL

Oncology Times, 2015
openaire   +1 more source